Control group:Placebo tablets
Sponsors
Peking University Third Hospital, The First Affiliated Hospital of Guangzhou Medical University, PLA General Hospital at Beijing
Conditions
Amyotrophic Lateral SclerosisCoronavirus disease 2019,COVID-19Pulmonary arterial hypertensioncoronary artery disease
Phase 2
A Study to Evaluate the Efficacy and Safety of TBN For Treatment of Patient With Amyotrophic Lateral Sclerosis
RecruitingChiCTR2000039689
Start: 2020-11-15Updated: 2021-02-16
A multicenter, open, single-dose acute hemodynamic study of MN-08 tablets in patients with pulmonary hypertension and a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of MN-08 tablets in the treatment of pulmonary hypertension
RecruitingChiCTR2100053623
Start: 2021-12-01Updated: 2022-10-17
Phase 4
Effect of vitamin D supplementation as an adjuvant therapy in Chinese patients with coronary artery disease: A Randomized Placebo-Controlled Trial
Active, not recruitingChiCTR-TRC-13003958
Start: 2013-12-01Updated: 2017-04-18
A Clinical Study of the Efficacy of Leritrelvir Tablets for Hospitalized Patients with Mild to Severe COVID-19
Active, not recruitingChiCTR2300072062
Start: 2023-06-01Updated: 2023-06-12